|
TPP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.184800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.752300E-02 |
| Normal-vs-Stage2 |
1.347740E-02 |
| Normal-vs-Stage3 |
3.356400E-03 |
| Normal-vs-Stage4 |
8.116800E-01 |
| Stage1-vs-Stage2 |
4.894400E-02 |
| Stage1-vs-Stage3 |
1.234180E-02 |
| Stage1-vs-Stage4 |
5.701200E-01 |
| Stage2-vs-Stage3 |
8.509800E-01 |
| Stage2-vs-Stage4 |
4.076300E-02 |
| Stage3-vs-Stage4 |
1.781940E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.135700E-03 |
| Normal-vs-AfricanAmerican |
3.540400E-02 |
| Normal-vs-Asian |
1.936830E-01 |
| Caucasian-vs-AfricanAmerican |
6.183200E-01 |
| Caucasian-vs-Asian |
3.312600E-01 |
| AfricanAmerican-vs-Asian |
2.129800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.321700E-02 |
| Normal-vs-Female |
1.095890E-03 |
| Male-vs-Female |
4.202300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.264100E-02 |
| Normal-vs-Extreme_Weight |
3.453800E-01 |
| Normal-vs-Obese |
2.131600E-02 |
| Normal-vs-Extreme_Obese |
5.217400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.057220E-01 |
| Normal_Weight-vs-Obese |
4.365800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.744400E-01 |
| Extreme_Weight-vs-Obese |
8.445800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.913200E-01 |
| Obese-vs-Extreme_Obese |
4.182200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.177700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.720900E-03 |
| Normal-vs-Age(61-80Yrs) |
3.569600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.858600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.639400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.632980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.482000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.235000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.213400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.737400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.619200E-01 |
| Normal-VS-Type2 PRCC |
3.96870000000105E-05 |
| Normal-VS-KIRP CIMP |
2.389600E-02 |
| Normal-VS-Unclassified PRCC |
1.721010E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.89460000000242E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.796200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.041700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.909430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.034600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.582200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.257000E-03 |
| Normal-vs-N1 |
1.979790E-02 |
| Normal-vs-N2 |
3.435800E-01 |
| N0-vs-N1 |
7.273400E-01 |
| N0-vs-N2 |
5.711400E-01 |
| N1-vs-N2 |
6.069000E-01 |
|
|
